发明名称 C-PHENYL 1-THIOGLUCITOL COMPOUND.
摘要 <p>A C-phenyl 1-thioglucitol compound represented by the formula (I), a pharmaceutically acceptable salt thereof, or a hydrate of the compound or the pharmaceutically acceptable salt. (I) wherein X represents a hydrogen atom or a C<sub>1-6</sub> alkyl group; Y represents a C<sub>1-6</sub> alkylene group or "O-(CH<sub>2</sub>)n- (n represents an integer ranging from 1 to 5); and Z represents "CONHRA or "NHCONHRB (provided that, when Z represents "NHCONHRB, n is not 1), where RA represents a C<sub>1-6</sub> alkyl group substituted by 1 to 3 groups independently selected from a hydroxyl group and "CONH<sub>2</sub>; and RB represents a hydrogen atom or a C<sub>1-6</sub> alkyl group substituted by 1 to 3 groups independently selected from a hydroxyl group and "CONH<sub>2</sub>. The compound, the salt or the solvate can inhibit the SGLT1 activity to prevent the absorption of glucose or the like, or can inhibit both the SGLT1 activity and the SGLT2 activity to prevent the absorption of glucose or the like and excrete a urine sugar, and is therefore useful as a prophylactic or therapeutic agent for diabetes.</p>
申请公布号 MX2008016231(A) 申请公布日期 2009.01.16
申请号 MX20080016231 申请日期 2007.06.28
申请人 TAISHO PHARMACEUTICAL CO., LTD. 发明人 KAKINUMA, HIROYUKI;HASHIMOTO, YUKO;OI, TAKAHIRO;TAKAHASHI, HITOMI;KOBASHI, YOHEI
分类号 C07D335/02;A61K31/382;A61P3/10;A61P43/00 主分类号 C07D335/02
代理机构 代理人
主权项
地址